Title: Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer
Authors: Dent, Rebecca A ×
Lindeman, Geoffrey J
Clemons, Mark
Wildiers, Hans
Chan, Arlene
McCarthy, Nicole J
Singer, Christian F
Lowe, Elizabeth S
Watkins, Claire L
Carmichael, James #
Issue Date: 2013
Publisher: Biomed Central Ltd
Series Title: Breast Cancer Research vol:15 issue:5
Article number: R88
Abstract: This Phase I study evaluated the safety, tolerability and efficacy of olaparib, a potent oral poly(ADP-ribose) polymerase (PARP) inhibitor, in combination with paclitaxel in patients with metastatic triple-negative breast cancer (mTNBC).
ISSN: 1465-542X
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Experimental Oncology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science